• Scheme Resolution passed by Requisite Majority of Cannatrek Shareholders
• 96.15% of Cannatrek Shareholders voted in favor of the Scheme Resolution
• Cannatrek to apply for Court approval of the Scheme on 24 April 2026
• Scheme expected to be implemented on 1 May 2026

Little Green Pharma Ltd (ASX:LGP) has provided an update on the Company's proposed acquisition of 100% of the issued capital of Cannatrek Ltd (Cannatrek) by way of scheme of arrangement. LGP advises that the Scheme Resolution was passed by the Requisite Majority of Cannatrek Shareholders at the Scheme Meeting held on 10 April 2026. 96.15% of Cannatrek Shareholders present and voting at the Scheme Meeting were in favor of the Scheme Resolution, and 98.44% of the total number of votes cast by Cannatrek Shareholders were in favor. Cannatrek will now apply to the Federal Court of Australia for approval of the Scheme at a hearing scheduled for 24 April 2026. If the Court approves the Scheme, Cannatrek intends to lodge a copy of the Court orders with ASIC on the same day, when the Scheme will become Effective. The Scheme is expected to be implemented on 1 May 2026. The announcement also provides an updated indicative timetable for key dates and events related to the Scheme.